Hypoallergenic molecules for subcutaneous immunotherapy

Expert Review of Clinical Immunology Volume 12, Issue 1, 2016

Editorials

Full text HTML

PDF

Free access

DOI:

10.1586/1744666X.2016.1103182

Laurian Jongejan^a, Ronald van Ree^ab & Lars K Poulsen^b*

pages 5-7

Publishing models and article dates explained

• Published online: 11 Nov 2015

Abstract

Although a large part of the population suffers from allergies, a cure is not yet available. Allergen-specific immunotherapy (AIT) offers promise for these patients. AIT has proven successful in insect and venom allergies; however, for food allergy this is still unclear. In this editorial we focus on the recent advances in a proof of concept study in food allergy, FAST (Food allergy specific immunotherapy), which may increase interest within the biomolecular and pharmaceutical industry to embark on similar projects of immunology driven precision medicine within the allergy field.

• Full text HTML
• PDF